Windward Bio Group AG (NasdaqGS: WWB)
Health Care · Biotechnology · CH
$24.01
+6.05% today · -15.8% 1Y
Public summary
A free snapshot of Windward Bio Group AG, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Windward Bio Group AG (NasdaqGS: WWB) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.39B and employs 33 people.
Over the last twelve months the share price has lost 15.8%, trading between 22.64 and 30.04.
Tweenvest scores Windward Bio Group AG across four factors: quality 58/100, value 100/100. Its strongest factor is value.
WWB price history
Key figures
- Market cap
- $1.39B
- Revenue (TTM)
- —
- P/E
- -20.43
- EPS
- -8.69
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $30.04
- 52-week low
- $22.64
- Avg volume (3M)
- —
- Shares outstanding
- 58.04M
- Employees
- 33
- Next earnings
- —
About Windward Bio Group AG
Operates as a holding company whose subsidiaries develops and commercializes therapeutics
- Founded
- 2024
- Listed since
- Nov 13, 2026
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Oncolys BioPharma Inc.TSE: 4588 | $1.41B | ¥7,620.00 | -5.69% |
| Intellia Therapeutics, Inc.NasdaqGM: NTLA | $1.41B | $10.05 | +5.51% |
| OliX Pharmaceuticals, IncKOSDAQ: A226950 | $1.41B | ₩82,400.00 | +4.97% |
| D&D Pharmatech Inc.KOSDAQ: A347850 | $1.40B | ₩40,700.00 | -2.51% |
| AnaptysBio, Inc.NasdaqGS: ANAB | $1.39B | $46.63 | -1.62% |
| Tyra Biosciences, Inc.NasdaqGS: TYRA | $1.38B | $20.03 | +1.32% |
| Immunocore Holdings plcNasdaqGS: IMCR | $1.38B | $26.63 | -3.20% |
| Wuhan Healthgen Biotechnology Corp.SHSE: 688765 | $1.37B | CN¥25.67 | -5.87% |